Patents by Inventor Bodo Lange

Bodo Lange has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical preparation that can be administered orally for treating fish, production method for said preparation and use of the latter
    Patent number: 8414947
    Abstract: The present invention is directed to a pharmaceutical preparation for oral application for treatment of fish, in particular for vaccination of fish of the salmon family and other fish having a comparable digestive system against bacterial and/or viral infections, in particular against VHS and IHN. The invention is also directed to a method for producing the preparation.
    Type: Grant
    Filed: December 13, 2005
    Date of Patent: April 9, 2013
    Assignee: Riemser Arzneimittel AG
    Inventors: Malte Adelmann, Dieter Fichtner, Bodo Lange, Werner Weitschies
  • Pharmaceutical Preparation that can be Administered Orally for Treating Fish, Production Method for Said Preparation and Use of the Latter
    Publication number: 20080317825
    Abstract: The present invention is directed to a pharmaceutical preparation for oral application for treatment of fish, in particular for vaccination of fish of the salmon family and other fish having a comparable digestive system against bacterial and/or viral infections, in particular against VHS and IHN. The invention is also directed to a method for producing the preparation.
    Type: Application
    Filed: December 13, 2005
    Publication date: December 25, 2008
    Applicant: RIEMSER ARZNEIMITTEL AG
    Inventors: Malte Adelmann, Dieter Fichtner, Bodo Lange, Werner Weitschies
  • Method based on localization of Hsp90 to the centrosome
    Patent number: 6335157
    Abstract: The present invention is directed to methods for screening for fragments, derivatives and analogs of Hsp90 that are altered in their subcellular localization, and thus, altered in their activity as compared to wild type Hsp90. The present invention is also directed to screening for modulators of Hsp90 activity as determined by assaying for altered subcellular localization of Hsp90. The present invention is further directed to diagnostic, prognostic and screening uses of Hsp90/centrosome co-purification.
    Type: Grant
    Filed: May 7, 1999
    Date of Patent: January 1, 2002
    Assignee: The European Molecular Biology Laboratory
    Inventors: Cayetano Gonzalez, Bodo Lange